baber/WOPTO huggingface dataset:
Patent AT-E282422-T1 (AT)
Inventor: MATSUYAMA FUTOSHI
IPC: A61K36/00
Filed: 2000-05-23
Granted: 2004-12-15
Abstract: A liquid composition to be vaporized for inhibiting an increase in blood sugar level which is prepared by dissolving or dispersing a concentrate of a hot water extract or alcohol extract of leaves of Lagerstroemia Speciosa, Linn. or Pers. as an active ingredient in an aqueous medium, a vaporizer for vaporizing the concentrate from a container containing the liquid composition by heating or nebulization and scattering it into the air, and a method of inhibiting an increase in blood sugar level by causing the vaporized active ingredient to be absorbed through the respiratory passage. According to the present invention, there are provided a liquid composition for inhibiting an increase in or lowering a blood sugar level by administration through the respiratory passage based on a new function and a vaporizer for the same.
Patent AT-E223804-T1 (AT)
Inventor: SCHLIMGEN STEFAN
IPC: B29C51/32
Filed: 2000-06-24
Granted: 2002-09-15
Abstract: Stacking method uses holding plates to transfer them from molding tool to stacking position where they are transferred to magazines from which stacks are transferred to conveyor. Stacking method is used for containers stamped out from thermoplastic sheet and fed by delivery devices to stacking magazines (11, 14, 16, 17), the stack (20) then being fed to a conveyor (18) which takes it off for further processing. Containers are removed from the lower section of the molding tool (1) by holding plates (6, 12). Each plate is then moved sideways to a stacking position (10, 13). The containers are then transferred into stacking magazines (11, 14). Each full magazine is passed to a sliding device (19, 21) which transfers the containers to conveyor, after which empty magazines are returned to the stacking position. An Independent claim is included for apparatus for carrying out the above method.
Patent AT-E273109-T1 (AT)
Inventor: CHIARI MAURO
IPC: B26F1/40
Filed: 2000-07-10
Granted: 2004-08-15
Abstract: Ejection tool for cutting wastes comprises a frame (2) made of two identical plates (10,12) separated by lateral and transversal bars (3,4). There are separating band (17) placed between the plate to maintain their shape. The plates are bored at regular intervals, with the holes (11) of each plate facing each other. Pins (30) are passing two facing holes.
Patent AT-E377216-T1 (AT)
Inventor: HAEFELE ULI
IPC: G06F17/30
Filed: 2000-07-28
Granted: 2007-11-15
Abstract: The network has several client computers, several network node computer units as well as several database computer units, whereby an input command or user-specific identity is entered to establish a connection from a client computer to a database via a node computer, whereupon information is requested from the database via the client computer. The node computer has an associated interface unit controlling a command analysis unit and an activation unit. At least one message can be output to the client computer unit depending on the association of request information to a class by a classification unit.
Patent AT-E305948-T1 (AT)
Inventor: HELLMANN UDO
IPC: C08J7/00
Filed: 2000-12-07
Granted: 2005-10-15
Abstract: Painting plastics substrates, which cleans the surface with an organic solvent and a mechanical surface treatment before coating with an adhesive layer of water-based adhesive to bond the applied paint. To paint plastics substrates, an adhesive layer is applied using a water-based adhesive with a further coating if required. Before the adhesive layer is applied, the surface of the plastics substrate is cleaned with an organic solvent or a mixture with an organic solvent content, together with one or more aliphatic and/or cycloaliphatic hydrocarbons with a boiling point of 25-315 degrees C and/or one or more aromatic hydrocarbons with a boiling point of 120-190 degrees C.   The mixture of hydrocarbons and solvent contains 1-20 wt% of one or more other solvents. The adhesive coating contains one or more chlorinated and/or chlorine-free polyolefins. The surface of the plastics substrate is treated mechanically at the same time as it is cleaned.
Patent AT-E364399-T1 (AT)
Inventor: SOBOLOV-JAYNES SUSAN BETH
IPC: A61K45/06
Filed: 2000-11-08
Granted: 2007-07-15
Abstract: The present invention relates to a method of treating depression or anxiety in a mammal, including a human, by administering to the mammal a CNS-penetrant NK-1 receptor antagonist (e.g., a substance P receptor antagonist) in combination with an antidepressant or an anxiolytic agent. It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier, a CNS-penetrant NK-1 receptor antagonist and an anxiolytic agent or antidepressant.
Patent AT-E278971-T1 (AT)
Inventor: GUERILLOT DOMINIQUE
IPC: G01V1/28
Filed: 2000-07-27
Granted: 2004-10-15
Abstract: A structure is chosen a priori, with one physical dimension (k) estimated from the exploration data and a second ( sigma ) estimated from the fluid production data. The model is optimized by iterative application of an inversion of at least one of the physical dimensions, which are related by a combination function. The final model at least satisfies the combination of the two dimensions. The iterative optimization involves a simultaneous iteration of the first and second physical dimensions with optimization of a global cost function J(K,  sigma ) of the two dimensions. The global cost function is the sum of terms measuring the spacing between the points of each model and the data obtained by measurement or observation or the corresponding dimension and the spacing taking into account the combination of the two dimensions. Each model is optimized by minimizing the objective function by determining its exact gradient using the adjoining state method. The production data are measured in the shaft through the underground area and the exploration data are the seismic data captured by seismic receivers in response to waves transmitted through the formation. The first physical dimension is the permeability of the medium and the second is the impedance of the medium relative to the waves.
Patent AT-E254339-T1 (AT)
Inventor: DREULLE CLAUDE MAURICE
Filed: 2000-03-10
Granted: 2003-11-15
Abstract: A box for a set of electric storage batteries for an electric motor vehicle includes at least two mutually opposite side walls (14, 16) extending substantially parallel and defining between them a housing for receiving batteries. Each side wall (14, 16) is internally provided with a series of projecting support elements (30, 32) extending along the wall, each support element (30,32) forming, jointly with a support element of the other side wall, a support for at least one rack of storage batteries.
Patent AT-E376029-T1 (AT)
Inventor: BERTRY JEAN-LOUIS
IPC: C08K5/00
Filed: 2000-04-05
Granted: 2007-11-15
Abstract: The invention relates to silicone compositions that are used in the production of varnishes that can be applied to supports in order to reduce the friction coefficient. The inventive composition comprises at least one polyorganosiloxane A (POS) which can be cationically and radically cross-linked by functional cross-linking groups (GFR) and a primer C chosen from onium borates, characterized in that the inventive composition also comprises molecules (POS D) which are substituted by secondary functional groups (GFS) carried by silicon atoms and selected from those that include at least one alkoxy and/or epoxy and/or carboxy motif and optionally a charge (e.g. silica). The invention can be used with anti-friction varnishes for RTV silicone coatings for material used in air bags, thermal transfer ribbons or packing films.
Patent AT-E327754-T1 (AT)
Inventor: SHAPIRO HOWARD M
IPC: G01N33/50
Filed: 2000-03-21
Granted: 2006-06-15
Abstract: The present invention is drawn to methods of killing bacteria, including antibiotic resistant bacteria, by contacting said bacteria with a membrane permeabilizing compound or combination of compounds and a membrane impermeant toxic agent or combination of agents, resulting in the death of the bacteria without substantial injury to the infected host or patient. The present invention is also drawn to compositions and kits for effecting the method of the present invention. The present invention is further drawn to methods of rendering toxic agents such as toxic organic molecules, membrane impermeant for use in the methods and compositions of the present invention.
Patent AT-E396649-T1 (AT)
Inventor: TICKNER E
IPC: A61B8/00
Filed: 2000-03-28
Granted: 2008-06-15
Abstract: A method is provided for measuring real time ambient pressure at a region of interest in a fluid-filled body cavity by introducing into the cavity a composition of gas-containing microbubbles having a predetermined fragility threshold correlating to the rupture response of their capsules to the ambient fluid pressure and/or applied acoustic pressure. An ultrasonic signal is applied at the region of interest at a power level sufficient to destroy the microbubble population having a fragility threshold below the applied power level. The ultrasound backscatter response is detected from the population of intact and disintegrating microbubbles remaining at the region of interest and this backscatter signal is correlated to predetermined acoustic response properties to determine the ambient pressure at the region of interest.
Patent AT-E298249-T1 (AT)
Inventor: GOTWALS PHILIP
IPC: A61K39/395
Filed: 2000-04-21
Granted: 2005-07-15
Abstract: Disclosed is a method of treating fibrosis in a human or animal subject. The method comprises administering to the subject an effective amount of an antibody to an integrin or fragment thereof.
Patent AT-E445013-T1 (AT)
Inventor: ITOH YASUAKI
IPC: A61K38/00
Filed: 2000-06-29
Granted: 2009-10-15
Abstract: The present invention relates to novel polypeptides and DNAs encoding the same, pharmaceutical compositions comprising the polypeptides or the DNAs, a screening method/screening kit for compounds or salts thereof that promote or inhibit the activity of the polypeptides, medicaments comprising the compounds or salts thereof, etc. The polypeptides of the present invention and DNAs encoding the same can be used for the diagnosis, treatment, prevention, etc. of, e.g., bone and joint diseases or pathological angiogenesis. Also, the polypeptides of the present invention are useful as reagents for screening the compounds or salts thereof that promote or inhibit the activity of the polypeptides. <IMAGE>
Patent AT-E320643-T1 (AT)
Inventor: GUM ARNOLD J
IPC: G08B23/00
Filed: 2000-07-17
Granted: 2006-04-15
Abstract: A system and method for aiding emergency service providers in locating an incapacitated individual by use of a wireless communications device. The invention has two major modes of operation based upon whether the line of communication between the handset and call destination is open or closed. If the connection between the handset and the call destination is open, the audible beacon periodically generates a preselected tone through the built-in speaker of the telephone. The audible beacon may be initiated from the call destination location, after there has been an established link between the telephone and the call destination, whether the connection is open or closed. Once the audible beacon is initiated, the stored volume settings of the handset are replaced by the volume settings of the audible beacon system and the preselected tone of a telephone ringer or a beep. The tone remains activated until manually turned off.
Patent AT-E227148-T1 (AT)
Inventor: FEUCHT PETER
IPC: A61F7/00
Filed: 2000-07-18
Granted: 2002-11-15
Abstract: A magnetic field applicator to heat magnetic substances in biological tissue, having a magnetic yoke with two pole shoes across from each other and separated from each other by a distance that defines the magnetic field exposure volume produced by the applicator, and with two magnetic coils, one assigned to each of the two pole shoes, to produce a magnetic field. The magnetic yoke and the pole shoes consist of ferrite segments assembled together. The pole shoes oppose each other and are surrounded by magnetic disk-shaped coils with one or more windings extending helicoidally, which creates an intermediate air gap between the pole shoes and coils. This results in a magnetic field applicator with the ability to effectively and efficiently administer hyperthermia and thermo-ablation procedures to destroy cancerous tissue in a patient, as well as having uses in other medical and industrial applications.
Patent AT-E330402-T1 (AT)
Inventor: FUKUNAGA KOJI
IPC: H04L12/40
Filed: 2000-08-31
Granted: 2006-07-15
Abstract: When a plurality of information signal processing apparatuses are connected via IEEE 1394 communication control buses, these buses are connected via bridges, and bus reset occurs on a remote bus other than connected buses (step S1501), occurrence of remote bus reset is notified (steps S1502, S1505). Thus, even if bus reset occurs, the consistency of bus reset processing in an upper protocol layer can be ensured to realize normal data communication between buses. <IMAGE>
Patent AT-E316073-T1 (AT)
Inventor: STEINMEYER ANDREAS
IPC: A61K31/59
Filed: 2000-07-24
Granted: 2006-02-15
Abstract: Vitamin D derivatives (I), having a cyclic substituent in the side-chain, are new. Also new are perhydroindane derivative intermediates (A) ands (B).  Vitamin D derivatives of formula (I), including all possible epimers, diastereomers and their mixtures, are new. Y1, Y2  =  H or -C(O)R5;  Y3 (in alpha- or beta-configuration)  =  H, OH, halo, OC(O)R5 or OR5;  R5  =  5-12C aromatic residue; or 1-12C optionally unsaturated alkyl (optionally interrupted by 1 or 2 O, 1 or 2 S and/or 1 or 2 NH; and optionally substituted by 1 or 2 OH, 1 or 2 NH2, 1 or 2 SH, 1 or 2 COOH and/or 1 or 2 COOH);  R1, R2  =  H or together form exocyclic =CH2;  R3, R4  =  H, F, Cl, Br or 1-4C alkyl;  or CR3R4  =  -C(=CH2)- or a 3-7 membered saturated or unsaturated carbocyclic ring;  Q  =  1-5C n-alkylene;  X1, X2  =  H, OH, OC(O)R5, F, Cl or Br (but not both OH or both -OC(O)R5);  or CX1X2  =  C=O;  Z'  =  carbocyclic or heterocyclic (including aromatic or heteroaromatic) ring system comprising a 5- or 6-membered ring optionally fused with a 6-membered ring (optionally substituted by one or more of each of halo, OH, COOR6 or 1-5C alkyl (itself optionally substituted by one or more of halo, 1-6C alkoxy and/or COOR6));  R6  =  1-6C alkyl, benzyl or phenyl. Independent claims are included for: (1) new perhydroindane derivative intermediates of formulae (A) and (B); (2) preparation of perhydroindane derivative intermediates of formula (XIIIa) by: (a) reacting a perhydroindane derivative of formula (A; T replaced by L) with protected, deprotonated propargyl alcohol to give (A; T = -CC-CH2OY5), (b) hydrogenating and deprotecting to give (A; T = -(CH2)3OH), (c) oxidizing to give (A; T = -CH2CH2CHO) and (d) reacting with a nucleophile Nu, cleaving Y4 and oxidizing the free OH group; and (3) preparation of vitamin D compounds of formula (IIa) by: (a) reacting a ketone of formula (XIIIb) with a trimethylsilyl acetoacetate ester in presence of a base or with a Wittig reagent in an aprotic solvent to give (B; U = COOR6), (b) reducing to give (B; U = CH2OH), (c) converting into (B; U replaced by L), (d) converting into the Wittig reagent (B; U = CH2P(O)(G)2) and (e) reacting with a ketone of formula (XXXIII) and optionally deprotecting the product.  T  =  -CC-CH2OY5, -(CH2)3OH or -CH2CH2CHO;  Y4  =  trialkylsilyl, mixed aryl-alkyl substituted silyl, tetrahydropyranyl or tetrahydrofuranyl protective group;  Y5  =  tetrahydropyranyl or benzyl;  E  =  side-chain, in which any keto and/or hydroxy groups are protected;  U  =  COOR6, CH2OH or CH2P(O)(G)2;  Y6  =  1-6C alkyl, benzyl or phenyl;  G  =  1-10C alkyl, 1-10C alkoxy, Ph or OPh;  L  =  leaving group;  Nu  =  nucleophile;  R7, R8  =  H or Me; or together form exocyclic =CH2 or a cyclopropane ring;  Y6  =  F, (CH2)nOH or (CH2)nOCOR5;  n  =  0-4;  Y'1  =  hydroxy-protecting group;  Y'3  =  H, halo or as Y'1.
Patent AT-E244608-T1 (AT)
Inventor: LALLEMENT FREDERIC
IPC: B05C17/02
Filed: 2000-09-13
Granted: 2003-07-15
Abstract: The invention concerns a device for painting characterised in that it comprises a support (100) formed by a handle (110), a wire (120) extending said handle (110) and forming an elbow (125) and a return bend (127) substantially transverse to the direction of the handle (110). Said device further comprises an element for applying paint (200) and means (300) for maintaining said element (200) on the support (100), means designed to be removably fixed in position on the return bend (127) of the support (100), said means (300) being capable of controlling the paint applying element (200) in rotation relative to the support (100).
Patent AT-E313631-T1 (AT)
Inventor: BLANCO DAVILA LUIS
IPC: G01N33/50
Filed: 2000-10-02
Granted: 2006-01-15
Abstract: The present invention relates to the identification and isolation of a DNA polymerase and uses of this polymerase. In particular, the present invention describes the nucleotide sequence of the human gene for DNA polymerase lambda (Pol λ), the amino acid sequence of Pol λ, and the amino acid sequence of several isoforms derived from alternative splicing of its mRNA. The association of some of these isoforms with tumour samples makes Pol λ a marker for the diagnosis, prognosis and evolution of tumoral processes.
Patent AT-E318883-T1 (AT)
Inventor: PARKER ANDREW P
IPC: C11D3/00
Filed: 2000-09-27
Granted: 2006-03-15
Abstract: Fabric care compositions adapted for use in a laundering process such as detergent compositions and laundry rinse compositions, comprise at least one reactive cationic polymer (preferably amine- or amide-epichlorohydrin resin or a derivative thereof), at least one reactive anionic polymer and at least one textile compatible carrier. The compositions have improved dye transfer and stain release properties and may be used in methods of treating fabric as part of a laundering process.
Patent AT-E314856-T1 (AT)
Inventor: ROBBINS JOAN M
IPC: C12N15/09
Filed: 2000-10-26
Granted: 2006-02-15
Abstract: As an effective therapy for proliferative skin and eye diseases such as psoriasis and proliferative diabetic retinopathy, this invention provides ribozymes and ribozyme delivery systems which cleave RNA encoding cytokines involved in inflammation, matrix metalloproteinases, a cyclin, a cell-cycle dependent kinase, a growth factor, or a reductase.
Patent AT-E289164-T1 (AT)
Inventor: HICK ALASTAIR JAMES
IPC: A01G7/00
Filed: 2000-12-11
Granted: 2005-03-15
Abstract: cis-Jasmone has been discovered to be useful as a semiochemical that changes the behavior of insects and/or the physiology of plants. It has direct signalling roles with plant-feeding aphids, in attraction of aphid predators and parasitoids, and may act as an airborne signal inducing production of volatile plant semiochemicals, including the monoterpene (E)-β-ocimene, that stimulate foraging by parasitoids. It is an extremely benign compound having, to human beings, a pleasant aroma and gives a long-lasting effect after removal of the stimulus.
Patent AT-E261403-T1 (AT)
Inventor: TULLY WILLIAM
IPC: A61K47/02
Filed: 2000-12-18
Granted: 2004-03-15
Abstract: A unit 1 for producing pyrogen controlled water on a small to medium factory scale comprises a number of charged ultrafiltration units 10 arranged in parallel. Orifice plates 15 are used to restrict and control the flow of deionized water to each filter 10. The filter units 10 are mounted on a frame 2 with a wheeled chassis 3 which may be pushed or moved by a forklift truck to a site where pyrogen controlled water is required. The unit 1 has an inlet line 4 for connection to a supply of deionized water and an outlet line 6 for connection to a user of pyrogen controlled water. The unit 1 may be purged with nitrogen from a supply 18. Sampling ports 17 in a common supply inlet 4 and a common outlet 6 ensure that the filtration efficiency can be closely monitored. The flow of water is monitored by a flowmeter 19 and pressure sensors 16 upstream of each filter facilitate a high level of control.
Patent AT-E420455-T1 (AT)
Inventor: BAILEY ANDREW
IPC: H05H1/46
Filed: 2000-11-14
Granted: 2009-01-15
Abstract: A plasma confinement arrangement for controlling the volume of a plasma while processing a substrate inside a process chamber using a plasma enhanced process is disclosed. The arrangement includes a first magnetic bucket having a plurality of first magnetic elements. The first magnetic elements being configured for producing a first magnetic field inside the process chamber. The arrangement further includes a second magnetic bucket having a plurality of second magnetic elements. The second magnetic elements being configured for producing a second magnetic field inside the process chamber. The second magnetic field being configured to combine with the first magnetic field to produce a resultant magnetic field between the first magnetic bucket and the second magnetic bucket. The resultant magnetic field being configured to permit by-product gas from the processing to pass through while substantially confining the plasma within a volume defined at least by the process chamber and the resultant magnetic field.
Patent AT-E329793-T1 (AT)
Inventor: NEUBERT JOACHIM
IPC: B60R16/02
Filed: 2001-04-12
Granted: 2006-07-15
Abstract: The system has a first conductor system (1) for a higher voltage and a second (2) for a lower voltage. The conductor systems have a first or second protection element (9,10) and contain an electrical load (3,4) and a common voltage reference point. A voltage comparator (14) is provided that taps the voltage on the input and output (15,16) of the second protection element (10) to detect a short circuit between the conductor systems. Independent claims are also included for the following: a method of detecting a short circuit in a supply system.
Patent AT-E475630-T1 (AT)
Inventor: KOSOKABE HIROYUKI
IPC: C03C3/089
Filed: 2001-05-16
Granted: 2010-08-15
Abstract: Glass, for encapsulating a semiconductor, which is substantially free of lead or other harmful ingredients, but which exhibits a sealing temperature of not higher than 710 DEG C, and which stably seals with Dumet. Further, when the glass has a viscosity of 10<6> dPa.s, the temperature of said glass is not higher than 710 DEG C, and includes two or more of Li2O, Na2O and K2O and B2O3. Also, the glass may comprise: SiO2, B2O3 and Al2O3 in an amount of from 40 to 70%, from 5 to 20% and from 0 to 15% by weight, respectively; MgO, CaO, SrO, BaO and ZnO in a total amount of from 0 to 45% by weight; and Li2O, Na2O and K2O in a total amount of from 5 to 25% by weight.
Patent AT-E272271-T1 (AT)
Inventor: KAEWELL JOHN D JR
IPC: H03M13/00
Filed: 1998-03-04
Granted: 2004-08-15
Abstract: A communication system where the data rate of a given transmission has been encoded by a transmitter and is then used to adjust a plurality of convolutional decoders sharing common memory. The system uses common processing resources to provide up to four discrete channels having multi-rate convolutional error correction decoding resulting in a reduced silicon area and low power operation. The system is capable of supporting data communication at 8 kbps up to 64 kbps for high rate ISDN communication in receivers of both base station and consumer unit locations.